Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 6,040.00
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026
TYO:4530 Ratios and Metrics
Market cap in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 7, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 425,225 | 422,541 | 308,076 | 293,429 | 303,688 | 296,969 | |
Market Cap Growth | 53.02% | 37.16% | 4.99% | -3.38% | 2.26% | -45.28% |
Enterprise Value | 311,836 | 316,844 | 196,769 | 173,093 | 157,504 | 157,000 |
Last Close Price | 6040.00 | 6030.00 | 4163.94 | 3738.10 | 3615.63 | 3384.30 |
PE Ratio | 22.52 | 22.05 | 14.16 | 21.01 | 25.86 | 30.75 |
Forward PE | 35.05 | 24.70 | 16.20 | 18.33 | 23.68 | 27.63 |
PS Ratio | 2.61 | 2.59 | 1.98 | 2.07 | 2.37 | 2.47 |
PB Ratio | 1.44 | 1.43 | 1.10 | 1.10 | 1.18 | 1.17 |
P/TBV Ratio | 1.48 | 1.48 | 1.14 | 1.14 | 1.19 | 1.18 |
P/FCF Ratio | 44.84 | 44.56 | 59.96 | 55.74 | 62.38 | 19.05 |
P/OCF Ratio | 24.33 | 24.18 | 16.42 | 16.13 | 23.86 | 15.47 |
EV/Sales Ratio | 1.91 | 1.94 | 1.26 | 1.22 | 1.23 | 1.31 |
EV/EBITDA Ratio | 12.14 | 12.69 | 7.80 | 9.44 | 9.52 | 11.50 |
EV/EBIT Ratio | 16.72 | 17.68 | 10.41 | 13.15 | 13.58 | 16.82 |
EV/FCF Ratio | 32.88 | 33.41 | 38.30 | 32.88 | 32.35 | 10.07 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.10 | 0.10 | 0.15 | 0.11 | 0.14 | 0.18 |
Debt / FCF Ratio | 0.25 | 0.25 | 0.75 | 0.40 | 0.47 | 0.16 |
Net Debt / Equity Ratio | -0.39 | -0.39 | -0.45 | -0.46 | -0.52 | -0.55 |
Net Debt / EBITDA Ratio | -4.66 | -4.66 | -4.96 | -6.72 | -8.13 | -10.25 |
Net Debt / FCF Ratio | -12.26 | -12.26 | -24.38 | -23.41 | -27.64 | -8.98 |
Asset Turnover | 0.46 | 0.46 | 0.46 | 0.44 | 0.42 | 0.40 |
Inventory Turnover | 2.77 | 2.77 | 2.98 | 3.13 | 3.15 | 2.87 |
Quick Ratio | 3.47 | 3.47 | 3.73 | 3.66 | 4.15 | 5.61 |
Current Ratio | 4.08 | 4.08 | 4.32 | 4.22 | 4.68 | 6.22 |
Return on Equity (ROE) | 6.81% | 6.81% | 8.16% | 5.49% | 4.72% | 3.88% |
Return on Assets (ROA) | 3.15% | 3.15% | 3.52% | 2.56% | 2.35% | 1.94% |
Return on Invested Capital (ROIC) | 8.67% | 8.91% | 9.86% | 7.40% | 7.31% | 6.07% |
Return on Capital Employed (ROCE) | 5.70% | 5.70% | 6.40% | 4.70% | 4.30% | 3.40% |
Earnings Yield | 4.51% | 4.53% | 7.06% | 4.76% | 3.87% | 3.25% |
FCF Yield | 2.23% | 2.24% | 1.67% | 1.79% | 1.60% | 5.25% |
Dividend Yield | 0.74% | 0.75% | 2.07% | 2.27% | 2.32% | 2.48% |
Payout Ratio | 39.63% | 39.63% | 29.96% | 47.09% | 57.22% | 70.81% |
Buyback Yield / Dilution | 3.10% | 3.10% | 4.27% | 3.03% | 2.29% | 0.63% |
Total Shareholder Return | 3.84% | 3.84% | 6.33% | 5.30% | 4.62% | 3.11% |